These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 9589640

  • 1. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
    Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S.
    J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
    [Abstract] [Full Text] [Related]

  • 2. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA, Maki KC, Unterman TG.
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M, Blum WF, Muche R, Heinze E, Haug C, Mayer H, Teller W.
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Dec; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 6. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
    Ricart W, Fernández-Real JM.
    Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
    [Abstract] [Full Text] [Related]

  • 7. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E, Fall CH, Seppälä M, Koistinen R, Dunkel L, Ylihärsilä H, Osmond C, Andersson S, Barker DJ, Forsén T, Holt RI, Phillips DI, Eriksson J.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [Abstract] [Full Text] [Related]

  • 8. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E, Velasco B, Barrios R, Sanchez-Franco F.
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [Abstract] [Full Text] [Related]

  • 9. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [Abstract] [Full Text] [Related]

  • 10. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ, Ghigo E.
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of GH stimulation on fasting and prandial metabolism and plasma IGFs and IGF-binding proteins in lean and obese sheep.
    McCann JP, Loo SC, Aalseth DL, Abribat T.
    J Endocrinol; 1997 Aug; 154(2):329-46. PubMed ID: 9291844
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [Abstract] [Full Text] [Related]

  • 13. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
    de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
    [Abstract] [Full Text] [Related]

  • 14. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM, Stenman S, Blum W, Kärkkäinen T, Lehtovirta P, Stenman UH.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [Abstract] [Full Text] [Related]

  • 15. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK, Huang CY, Liou YJ, Wang CK, Lee SD.
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [Abstract] [Full Text] [Related]

  • 16. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 17. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.
    Street ME, Smerieri A, Montanini L, Predieri B, Iughetti L, Valenzise M, De Luca F, Vigone M, Weber G, Maghnie M, Bernasconi S.
    J Biol Regul Homeost Agents; 2013 Nov; 27(1):259-66. PubMed ID: 23489706
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children.
    Park MJ, Kim HS, Kang JH, Kim DH, Chung CY.
    J Pediatr Endocrinol Metab; 1999 Dec; 12(2):139-44. PubMed ID: 10392359
    [Abstract] [Full Text] [Related]

  • 20. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF, Segovia B, Lassarre C, Binoux M, Gourmelen M.
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.